106898-71-9

Basic information

• Product Name: 2-[(1-METHYLETHYL)AMINO]BENZYL ALCOHOL
• Synonyms: 2-[(1-METHYLETHYL)AMINO]BENZYL ALCOHOL;[2-(Isopropylamino)Phenyl]Methanol
• CAS NO: 106898-71-9
• Molecular Formula: C₁₀H₁₅NO
• Molecular Weight: 165.23
• Mol File: 106898-71-9.mol
• Article Data: 10

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 2-[(1-METHYLETHYL)AMINO]BENZYL ALCOHOL(CAS DataBase Reference)
• NIST Chemistry Reference: 2-[(1-METHYLETHYL)AMINO]BENZYL ALCOHOL(106898-71-9)
• EPA Substance Registry System: 2-[(1-METHYLETHYL)AMINO]BENZYL ALCOHOL(106898-71-9)

Safety Data

• Hazardous Substances Data: 106898-71-9(Hazardous Substances Data)

Usage

Structure

Benzyl alcohol derivative with an amino group (-NH2) and an isopropyl group (-CH(CH3)2) attached to the benzene ring

Appearance

White to pale yellow

Uses

Production of pharmaceuticals, cosmetics, and personal care products

Known for

Antiseptic and antibacterial properties; commonly used in topical antiseptics and disinfectants

Also used as

Fragrance ingredient in various products

Industry applications

Medical and cosmetic industries

Versatility

Wide range of applications due to its properties and uses

Upstream product

• 5226-51-7 2,2-dimethyl-1,4-dihydro-2H-3,1-benzoxazine 
• 5344-90-1 2-Aminobenzyl alcohol 
• 67-64-1 acetone 
• 14723-39-8 2,2-dimethyl-3,4-dihydro-2H-benzo[e][1,3]oxazine 

Downstream Products

• 18023-30-8 2,2-dimethyl-2,3-dihydro-1H-indole 
• 106898-76-4 (E)-3-[(2-Hydroxymethyl-phenyl)-isopropyl-carbamoyl]-acrylic acid ethyl ester 
• 7732-18-5 water 
• 103718-15-6 2-(isopropylamino)benzaldehyde 
• 158577-01-6 1-isopropyl-2-oxo-1,2-dihydroquinoline-3-carboxylic acid 
• 174486-39-6 N-(endo-8-(3-hydroxy)propyl-8-azabicyclo[3.2.1]oct-3-yl)-1-isopropyl-2-oxo-1,2-dihydro-3-quinolinecarboxamide 
• 128936-16-3 2-[(2-isopropylamino)benzylsulfinyl]imidazole 
• 866933-46-2 Velusetrag 

Relevant articles and documents

Prokinetic agent for bowel preparation

The invention provides methods of bowel preparation before a diagnostic, surgical or therapeutic procedure, in particular, bowel preparation before a colonoscopy procedure, using a 5-HT4 receptor agonist as a prokinetic agent.

Quinolinone-carboxamide compounds

The invention provides novel quinolinone-carboxamide 5-HT4 receptor agonist compounds. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with 5-HT4 receptor activity, and processes and intermediates useful for preparing such compounds.

Crystalline form of a quinolinone-carboxamide compound

The invention provides a crystalline hydrochloride salt of 1-isopropyl-2-oxo-1,2-dihydroquinoline-3-carboxylic acid {(1S,3R,5R)-8-[(R)-2-hydroxy-3-(methanesulfonyl-methyl-amino)propyl]-8-azabicyclo[3.2.1]oct-3-yl}amide or a solvate thereof. The invention also provides pharmaceutical compositions comprising such crystalline salt forms, methods of using such crystalline salt forms to treat diseases associated with 5-HT4 receptor activity, and processes useful for preparing such crystalline salt forms.